Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225758421> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W4225758421 abstract "What is already known about this topic? Secukinumab, an interleukin-17A inhibitor, has previously been reported to have significantly higher efficacy in head-to-head trials vs. etanercept and ustekinumab in patients with moderate-to-severe plaque psoriasis. What does this study add? The results of the study provide valuable head-to-head data on the efficacy of two biologics with different mechanisms of action (secukinumab and adalimumab) as first-line biological monotherapy for patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis. The findings of this study can further help physicians to make informed and evidence-based decisions for the treatment of patients with active psoriatic arthritis who have concomitant moderate-to-severe plaque psoriasis. Linked Comment: E. Sbidian and L. Pina-Vegas. Br J Dermatol 2021; 185:1085." @default.
- W4225758421 created "2022-05-05" @default.
- W4225758421 date "2021-12-01" @default.
- W4225758421 modified "2023-09-27" @default.
- W4225758421 doi "https://doi.org/10.1111/bjd.v185.6" @default.
- W4225758421 hasPublicationYear "2021" @default.
- W4225758421 type Work @default.
- W4225758421 citedByCount "2" @default.
- W4225758421 countsByYear W42257584212023 @default.
- W4225758421 crossrefType "journal-issue" @default.
- W4225758421 hasConcept C126322002 @default.
- W4225758421 hasConcept C16005928 @default.
- W4225758421 hasConcept C17991360 @default.
- W4225758421 hasConcept C2776260265 @default.
- W4225758421 hasConcept C2777226972 @default.
- W4225758421 hasConcept C2778975655 @default.
- W4225758421 hasConcept C2779384505 @default.
- W4225758421 hasConcept C2779745271 @default.
- W4225758421 hasConcept C2779786854 @default.
- W4225758421 hasConcept C2780132546 @default.
- W4225758421 hasConcept C2780564577 @default.
- W4225758421 hasConcept C3020604521 @default.
- W4225758421 hasConcept C71924100 @default.
- W4225758421 hasConceptScore W4225758421C126322002 @default.
- W4225758421 hasConceptScore W4225758421C16005928 @default.
- W4225758421 hasConceptScore W4225758421C17991360 @default.
- W4225758421 hasConceptScore W4225758421C2776260265 @default.
- W4225758421 hasConceptScore W4225758421C2777226972 @default.
- W4225758421 hasConceptScore W4225758421C2778975655 @default.
- W4225758421 hasConceptScore W4225758421C2779384505 @default.
- W4225758421 hasConceptScore W4225758421C2779745271 @default.
- W4225758421 hasConceptScore W4225758421C2779786854 @default.
- W4225758421 hasConceptScore W4225758421C2780132546 @default.
- W4225758421 hasConceptScore W4225758421C2780564577 @default.
- W4225758421 hasConceptScore W4225758421C3020604521 @default.
- W4225758421 hasConceptScore W4225758421C71924100 @default.
- W4225758421 hasIssue "6" @default.
- W4225758421 hasLocation W42257584211 @default.
- W4225758421 hasOpenAccess W4225758421 @default.
- W4225758421 hasPrimaryLocation W42257584211 @default.
- W4225758421 hasRelatedWork W1970925217 @default.
- W4225758421 hasRelatedWork W2007444191 @default.
- W4225758421 hasRelatedWork W2745529784 @default.
- W4225758421 hasRelatedWork W2984218665 @default.
- W4225758421 hasRelatedWork W3202364329 @default.
- W4225758421 hasRelatedWork W4213351251 @default.
- W4225758421 hasRelatedWork W4248008924 @default.
- W4225758421 hasRelatedWork W4291309965 @default.
- W4225758421 hasRelatedWork W4295258044 @default.
- W4225758421 hasRelatedWork W4324149340 @default.
- W4225758421 hasVolume "185" @default.
- W4225758421 isParatext "false" @default.
- W4225758421 isRetracted "false" @default.
- W4225758421 workType "paratext" @default.